NCT00068172 2022-06-27
Study of PI-88 in Patients With Advanced Melanoma
Cellxpert Biotechnology Corp.
Phase 1/2 Completed
Clinical Trials
8 trialsNCT00073892 2022-06-27
PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma
Cellxpert Biotechnology Corp.
Phase 1/2 Completed
NCT00097851 2022-06-27
Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
Cellxpert Biotechnology Corp.
Phase 2 Completed
NCT00103389 2022-06-27
Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Cellxpert Biotechnology Corp.
Phase 2 Completed
NCT00247728 2022-06-23
PI-88 in Hepatocellular Carcinoma After Hepatectomy
Cellxpert Biotechnology Corp.
Phase 2 Completed
NCT01402908 2022-06-23
PATRON
Cellxpert Biotechnology Corp.
Phase 3 Terminated
NCT00268593 2011-06-15
Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
Progen Pharmaceuticals
Phase 2 Completed
NCT00568308 2011-06-15
PATHWAY
Progen Pharmaceuticals
Phase 3 Terminated